Morphosys moves closer to getting first antibody drug on market
 

Morphosys moves closer to getting first antibody drug on market
FRANKFURT, Oct 1 (Reuters) - German biotech Morphosys moved a step closer to getting its first antibody drugonto the market as its licensee, Johnson & Johnson unit Jenssen, reported positive results from a phase 3 study ofpsoriasis drug guselkumab.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...SE:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...SE:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/Oq1UB3yueB0